Amlodipine Besylate And Benazepril Hydrochloride
NDC Package 58118-2272-3
Package Information
Amlodipine Besylate And Benazepril Hydrochloride is amlodipine Besylate and Benazepril Hydrochloride Capsules are contraindicated in patients with a history of angioedema, with or without previous ACE inhibitor treatment, or patients who are hypersensitive to benazepril, to any other ACE inhibitor, or to amlodipine. Marketed by Clinical Solutions Wholesale, this product is identified by NDC 58118-2272 and is authorized under FDA application NDA020364.
Identification & Billing
- RxCUI: 898342 - amLODIPine besylate 10 MG / benazepril HCl 20 MG Oral Capsule
- RxCUI: 898342 - amlodipine 10 MG / benazepril hydrochloride 20 MG Oral Capsule
- RxCUI: 898342 - amlodipine (as amlodipine besylate) 10 MG / benazepril hydrochloride 20 MG Oral Capsule
- RxCUI: 898342 - Amlodipine 10 MG / BZP hydrochloride 20 MG Oral Capsule
- RxCUI: 898346 - amLODIPine besylate 10 MG / benazepril HCl 40 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 58118 - Clinical Solutions Wholesale
- 58118-2272 - Amlodipine Besylate And Benazepril Hydrochloride
- 58118-2272-3 - 30 CAPSULE in 1 BOTTLE, PLASTIC
- 58118-2272 - Amlodipine Besylate And Benazepril Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (58118-2272). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 58118-2272-3 identifies a specific commercial package of 30 capsule in 1 bottle, plastic of Amlodipine Besylate And Benazepril Hydrochloride, labeled by Clinical Solutions Wholesale. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Clinical Solutions Wholesale on March 03, 1995. The current certification is valid through June 22, 2017.
How is this Clinical Solutions Wholesale product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 58118227203. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.